785 related articles for article (PubMed ID: 34692770)
1. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
Zheng H; Liu H; Li H; Dou W; Wang X
Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
[No Abstract] [Full Text] [Related]
2. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis.
Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY
Front Oncol; 2023; 13():1191660. PubMed ID: 37207166
[TBL] [Abstract][Full Text] [Related]
3. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
Zheng H; Liu H; Ge Y; Wang X
Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
[TBL] [Abstract][Full Text] [Related]
4. Influential upregulation of KCNE4: Propelling cancer associated fibroblasts-driven colorectal cancer progression.
Zhang Z; Liu S; Wang Z; Wang S; Jiang L; Wang X; Li J; Shen L
Cancer Cell Int; 2024 Mar; 24(1):103. PubMed ID: 38462626
[TBL] [Abstract][Full Text] [Related]
5. A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response.
Lv Y; Hu J; Zheng W; Shan L; Bai B; Zhu H; Dai S
Transl Cancer Res; 2023 Sep; 12(9):2256-2275. PubMed ID: 37859738
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer.
Wu ZZ; Wei YJ; Li T; Zheng J; Liu YF; Han M
World J Clin Cases; 2024 Feb; 12(4):700-720. PubMed ID: 38322675
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics.
Gu L; Ding D; Wei C; Zhou D
Front Oncol; 2023; 13():1158863. PubMed ID: 37404754
[TBL] [Abstract][Full Text] [Related]
8. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer.
Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH
Front Genet; 2022; 13():1054152. PubMed ID: 36506313
[No Abstract] [Full Text] [Related]
10. Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma.
Gu Y; Zhuo H
Aging Male; 2023 Dec; 26(1):2233609. PubMed ID: 37428096
[TBL] [Abstract][Full Text] [Related]
11. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
[TBL] [Abstract][Full Text] [Related]
12. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
13. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
14. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma.
Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K
Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of cancer-associated fibroblast signature in gastric cancer.
Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C
Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer.
Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H
Front Genet; 2022; 13():957655. PubMed ID: 36105100
[No Abstract] [Full Text] [Related]
18. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer.
Zhang J; Zhang N; Fu X; Wang W; Liu H; McKay MJ; Dejkriengkraikul P; Nie Y
Ann Transl Med; 2022 Jun; 10(12):698. PubMed ID: 35845527
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]